No results for ‘’
Bajaj Healthcare Ltd
₹333.30
(0.12%)
Sat, 19 Sept 2026, 03:35 pm
Health Technology
Pharmaceuticals: Major
24.5KBajaj Healthcare EV/EBITDA Ratio
| Particulars | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 0 | 0 | 0 | 0 | 0 | 0 | 28.58 | 18.17 | 17.98 | 11.24 | 7.83 | 13.16 | 19.55 | 0 | 51.20 |
| Price to book ratio | 0 | 0 | 0 | 0 | 0 | 0 | 2.27 | 2.43 | 2.27 | 1.59 | 2.52 | 2.86 | 2.29 | 2.90 | 4.55 |
| Price to sales ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0.97 | 0.95 | 0.79 | 0.69 | 0.99 | 1.38 | 1.30 | 1.71 | 3.73 |
| Price to cash flow ratio | 0 | 0 | 0 | 0 | 0 | 0 | 14.81 | 29.84 | 16.85 | 19.66 | 18.37 | 0 | 0 | 15.91 | 0 |
| Enterprise value | 0 | 0 | 0 | 0 | 0 | 0 | 297Cr | 353Cr | 364Cr | 371Cr | 817Cr | 1194Cr | 1237Cr | 1137Cr | 2241Cr |
| Enterprise value to EBITDA ratio | 0 | 0 | 0 | 0 | 0 | 0 | 9.15 | 8.50 | 7.63 | 6.61 | 5.80 | 9.66 | 10.91 | 33.23 | 26.85 |
| Debt to equity ratio | 1.57 | 2 | 2.39 | 2.25 | 1.77 | 0.92 | 0.76 | 0.76 | 0.63 | 0.51 | 0.70 | 0.78 | 1.13 | 1.20 | 0.48 |
| Return on equity % | 0 | 2.16 | -3.54 | 6.50 | 21.44 | 12.87 | 8.34 | 14.29 | 13.44 | 16.44 | 40.54 | 24.33 | 18.25 | -4.44 | 11.53 |
Bajaj Healthcare Ltd Enterprise Value to EBITDA Ratio
The Bajaj Healthcare Ltd Enterprise Value to EBITDA Ratio is a key financial metric used by investors to evaluate Bajaj Healthcare Ltd's valuation, profitability, and overall financial performance. Tracking the Bajaj Healthcare Ltd Enterprise Value to EBITDA Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Bajaj Healthcare Ltd (NSE: BAJAJHCARE, BSE: 539872) is currently trading at ₹333.30, with a market capitalization of ₹1120.63Cr. As a leading company in the Health technology sector and Pharmaceuticals: major industry, monitoring the Bajaj Healthcare Ltd Enterprise Value to EBITDA Ratio is essential for fundamental analysis.
Bajaj Healthcare Ltd Enterprise Value to EBITDA Ratio Current Value
The current Bajaj Healthcare Ltd Enterprise Value to EBITDA Ratio stands at 26.85.
The Bajaj Healthcare Ltd Enterprise Value to EBITDA Ratio has declined compared to earlier levels, suggesting improved fundamentals or more attractive valuation.
Bajaj Healthcare Ltd Enterprise Value to EBITDA Ratio Historical Trend
The Bajaj Healthcare Ltd Enterprise Value to EBITDA Ratio has shown the following historical trend:
- 2024: 26.85
- 2023: 33.23
- 2022: 10.91
- 2021: 9.66
- 2020: 5.80
The decline in Bajaj Healthcare Ltd Enterprise Value to EBITDA Ratio indicates improving financial efficiency or better earnings growth.
What Bajaj Healthcare Ltd Enterprise Value to EBITDA Ratio Indicates for Investors
The Bajaj Healthcare Ltd Enterprise Value to EBITDA Ratio plays a crucial role in understanding the company's financial health and valuation.
This ratio is an important metric used in fundamental analysis of Bajaj Healthcare Ltd.
Bajaj Healthcare Ltd Enterprise Value to EBITDA Ratio Analysis Summary
The Bajaj Healthcare Ltd Enterprise Value to EBITDA Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Bajaj Healthcare Ltd Enterprise Value to EBITDA Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Bajaj Healthcare Ltd Enterprise Value to EBITDA Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.